Trial drug can significantly block early stages of COVID-19 in engineered human tissues

by ossmanagement_5ljjkf • April 2, 2020

An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. …read more

Source:: Science

Install the latest version of the Docker engine to avoid vulnerabilities

Systemd can't seem to catch a break: New vulnerability found

KDE is to Linux what 7 was to Windows

Let the Linux kernel Rust

The best email client for Linux, Windows and macOS isn't Outlook

Red Hat expands its reach into academia and research institutions